glp-1 for anxiety GLP-1s linked to lower rates of and depression than an older anti-obesity drug — not higher. #GLP1 #Semaglutide #Tirzepatide #ObesityMedicine #MentalHealth #Anxiety #Depression #Neuropsychiatry #ObesityTreatment #WeightManagement #Naltrexone New research from our team

nomenclature verified via The Plant List, , accessed February 24, 2025) holds particular significance

For subjects treated with the highest dose of tirzepatide (15 mg per week), the risk to develop any major adverse cardiovascular event (MACE-4 composed of myocardial infarction, stroke, hospitalization for angina, and all-cause death) was estimated at 050 (026095)

A key overall point is that retention of LDL leads to oxidative modification of LDL, allowing this oxidized LDL (oxLDL) to be recognized by scavenger receptors on macrophages and other cells

By covalent (albiglutide, dulaglutide) or no-covalent (semaglutide) coupling to larger molecules with slow clearance, analogs with even more prolonged activity have been produced so that there are now several once-weekly agonists on the market

Data analysis plan Analyses will be based on two defined analysis sets: an intention-to-treat (ITT) analysis set and a per-protocol (PP) analysis set